Mead Johnson Nutrition (NYSE: MJN ) reported earnings on Jan. 31. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Mead Johnson Nutrition beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew and GAAP earnings per share grew significantly.
Gross margins were steady, operating margins were steady, net margins increased.
Mead Johnson Nutrition recorded revenue of $981.1 million. The 12 analysts polled by S&P Capital IQ expected to see sales of $954.8 million on the same basis. GAAP reported sales were 7.7% higher than the prior-year quarter's $911.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.72. The 15 earnings estimates compiled by S&P Capital IQ forecast $0.68 per share. GAAP EPS of $0.66 for Q4 were 61% higher than the prior-year quarter's $0.41 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 61.1%, about the same as the prior-year quarter. Operating margin was 19.3%, about the same as the prior-year quarter. Net margin was 13.7%, 430 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.04 billion. On the bottom line, the average EPS estimate is $0.88.
Next year's average estimate for revenue is $4.16 billion. The average EPS estimate is $3.33.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 80 members out of 96 rating the stock outperform, and 16 members rating it underperform. Among 33 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 26 give Mead Johnson Nutrition a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mead Johnson Nutrition is outperform, with an average price target of $72.07.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.